Skip to main content

Table 2 Main data of patients regarding medical history and functional outcome according to MSTS-score. Indication for TFR was periprosthetic fracture (Group A) of aseptic loosening (Group B)

From: Short- to long-term follow-up of total femoral replacement in non-oncologic patients

Group/Patient Number

Arthroplasty prior reconstruction with TFR

Age at reconstruction with TFR

Number of Revisions prior to TFR

Follow-up (months)

MSTS Score

A/1

DFP and HP

76

3

132

15

Group A: 10 (±5)

A/2

DFP and HP

67

5

45

15

A/3

PFP and KP

81

7

78

10

A/4

DFP and HP

76

3

79

11

A/5

Nail and HP

71

3

79

12

A/6

HP

69

2

99

14

A/7

HP and KP

70

7

87

13

A/8

KP

84

1

54

4

A/9

KP

86

8

45

1

A/10

HP and KP

74

1

85

8

A/11

Nail and KP

90

4

111

6

B/12

HP and KP

79

1

58

8

Group B: 10 (±4)

B/13

KP

70

2

67

15

B/14

DFP

85

2

121

5

B/15

HP and KP

88

1

28

7

B/16

HP

70

1

109

9

B/17

HP

83

2

76

15

B/18

HP and KP

77

3

80

10

Mean

78

3

80

10

 

Standard deviation

7

2

28

4

 
  1. MSTS musculoskeletal tumor society (MSTS-score is given as patient-specific mean score and group-specific mean score), HP hip prosthesis, KP knee prosthesis, DFP distal femoral prosthesis, PFP proximal femoral prosthesis